Perceived Disability and Lifestyle Modification Following Hospitalization for Non-ST Elevation Versus ST Elevation Acute Coronary Syndromes: The Patients' Point of View

Abstract

Background and aims: Medical personnel generally believe that non-ST elevation (NSTE) acute coronary syndromes (ACS) are less damaging than ST elevation myocardial infarction (STEMI), in keeping with the lower morbidity and mortality attributed to these subgroups in randomized clinical trials. We examined whether this concept translates into a difference from the patients' point of view regarding lifestyle modification and return to work following hospitalization for ACS.

Methods: A structured anonymous self-completed questionnaire was mailed and returned by 160 consecutive patients (age 64 ± 11 years; 125 (78%) men) 3–12 months after hospitalization for ACS. In 49 patients, the diagnosis was unstable angina pectoris (UAP), in 34 non-ST elevation myocardial infarction (NSTEMI) and in 73, ST elevation myocardial infarction (STEMI). The questionnaire addressed issues relating to demographic data, medical history, occupation, employment and income before the acute event, changes following hospitalization for ACS and questions relating to current perceived health status and return to work.

Results: Most (98/159, 62%) patients saw themselves as “heart patients” after hospitalization for ACS. Quality of life was perceived to have decreased in 70 (44%), self-image in 85 (53%), self-confidence in 78 (49%) and sexual function in 75 (48%), with no differences according to ACS type. Anxiety was reported by 85 (54%) patients and anxiety level (1.47 ± 1.25 on the Brief Symptom Inventory scale) was high. Only 38 (49%) of 77 patients who were working prior to the acute event returned to full- or part-time gainful employment. By multivariate analysis, return to work was associated with 3 variables: younger age (p = 0.015), shorter duration of hospitalization (p = 0.036) and higher income bracket prior to the acute event (p = 0.0001), with no relation to gender, in-hospitalization revascularization strategy, rehabilitation program or to underlying cardiac diagnosis (UAP, NSTEMI or STEMI).

Conclusions: Hospitalization for ACS had a major negative impact on patient lifestyle and return to work, irrespective of the underlying cardiac diagnosis. The experience of hospitalization for an acute heart condition was uniformly traumatic with in many instances a prolonged adverse effect on patient function.

Keywords

Acute coronary syndrome Lifestyle modification Disability Employment

Get full access to this article

View all access options for this article.

References

[1]

Braunwald

Antman

E.M.

Beasley

J.W.

Califf

R.M.

Cheitlin

M.D.

Hochman

J.S.

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)

J Am Coll Cardiol 40 2002 1366–1374

[2]

Antman

E.M.

Anbe

D.T.

Armstrong

P.W.

Bates

E.R.

Green

L.A.

Hand

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction)

J Am Coll Cardiol 44 2004 671–719

[3]

Giugliano

R.P.

Braunwald

2004 ACC/AHA guideline for the management of patients with STEMI: the implications for clinicians

fs 2 2005 114–115

[4]

Yuval

Halon

D.A.

Merdler

Khader

Karkabi

Uziel

Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction

Arch Int Med 160 2000 1142–1146

[5]

Yuval

Halon

D.A.

Lewis

B.S.

Patients' point of view in heart failure trials

JAMA 285 2001 883–884

[6]

Yuval

Uziel

Gordon

Merdler

Khader

Karkabi

Perceived benefit after participating in positive and negative/neutral heart failure trials: the patients' perspective

Eur J Heart Fail 3 2001 217–223

[7]

Yuval

Halon

D.A.

Flugelman

M.Y.

Lewis

B.S.

Perceived patient comprehension in acute and chronic cardiovascular clinical trials

Cardiology 99 2003 68–71

[8] The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators (CURE)

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

N Engl J Med 345 2001 494–502

[9]

Cannon

C.P.

McCabe

C.H.

Wilcox

R.G.

Langer

Caspi

Berink

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial

Circulation 102 2000 149–156

10.

[10]

Antman

E.M.

Morrow

D.A.

McCabe

C.H.

Murphy

S.A.

Ruda

Sadowshi

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

N Engl J Med 354 2006 1477–1488

11.

[11]

Sabatine

M.S.

Cannon

C.P.

Gibson

C.M.

Lopez-Sendon

J.L.

Montalescot

Theroux

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

N Engl J Med 352 2005 1179–1189

12.

[12]

Marzilli

Ranolazine

C.V.

Therapeutics

Curr Opin Investig Drugs 6 2005 336–343

13.

[13]

Derogatis

L.R.

Melisaratos

The Brief Symptom Inventory: an introductory report

Psychol Med 13 1983 595–605

14.

[14]

Moser

D.K.

Dracup

McKinley

Yamasaki

Kim

C.J.

Riegel

An international perspective on gender differences in anxiety early after acute myocardial infarction

Psychosom Med 65 2003 511–516

15.

16.

[16]

Mallik

Spertus

J.A.

Reid

K.J.

Krumholz

H.M.

Rumsfeld

J.S.

Weintraub

W.S.

Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women

Arch Intern Med 166 2006 876–883

17.

[17]

Mulcahy

Kennedy

Conroy

The long-term work record of post-infarction patients subjected to an informal rehabilitation and secondary prevention programme

Eur Heart J 9 1988 84–88 [Suppl L]

18.

[18]

Dennis

Houston-Miller

Schwartz

R.G.

Ahn

D.K.

Kraemer

H.C.

Gossard

Early return to work after uncomplicated myocardial infarction. Results of a randomized trial

JAMA 260 1988 214–220

19.

[19]

Picard

M.H.

Dennis

Schwartz

R.G.

Ahn

D.K.

Kraemer

H.C.

Berger

W.E.

3rd

Cost–benefit analysis of early return to work after uncomplicated acute myocardial infarction

Am J Cardiol 63 1989 1308–1314

20.

[20]

Kovoor

Lee

A.K.

Carrozzi

Wiseman

Byth

Zecchin

Return to full normal activities including work at two weeks after acute myocardial infarction

Am J Cardiol 97 2006 952–958

21.

[21]

Topol

E.J.

Burek

O'Neill

W.W.

Kewman

D.G.

Kander

N.H.

Shea

M.J.

A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion

N Engl J Med 318 1988 1083–1088

22.

[22]

Antman

E.M.

Cohen

Radley

McCabe

Rush

Premmereur

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

Circulation 100 1999 1602–1608

23.

[23]

Yusuf

Mehta

S.R.

Chrolavicius

Afzal

Pogue

Granger

C.B.

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

N Engl J Med 354 2006 1464–1476

24.

[24]

Yusuf

Mehta

S.R.

Chrolavicius

Afzal

Pogue

Granger

C.B.

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

JAMA 295 2006 1519–1530

25.

[25]

Oterhals

Hanestad

B.R.

Eide

G.E.

Hanssen

T.A.

The relationship between in-hospital information and patient satisfaction after acute myocardial infarction

Eur J Cardiovasc Nurs 5 2006 303–310